Opendata, web and dolomites

H2020 projects about "metastatic"

The page lists 138 projects related to the topic "metastatic".

# achronym  title  year 
1 PROCROP Professional cross-priming for ovary and prostate cancer 2015
2 INTRAHETEROSEQ Molecular characterization of the role of intra-tumor heterogeneity in cancer progression and metastasis 2015
3 EPICUP Development of a ncRNA DNA Methylation Kit for the Diagnosis of Cancer of Unknown Primary 2015
4 A CACTUS Antibody-free method for Counting All Circulating TUmour cellS while maintaining them alive and intact 2015
5 Cancer-Targeted PolyIC Treatment of EGFR over-expressing cancers by targeted non-viral delivery of PolyIC 2015
6 MAGICBULLET Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy 2015
7 BioGuidePCa Biomarker Guided Prostate Cancer Management 2014
8 Brain Metastases The Role of Circulating Monocytes in the Development of Brain Metastases 2015
9 Cdc42Adhere Role of Cdc42 in cancer cell adhesion to endothelial cells and platelets 2015
10 GENMETASTEM GENOMIC AND METABOLIC REGULATION OF METASTATIC CANCER STEM CELLS 2016
11 MACROIMAGING Specific Fluorogenic Peptides for Imaging Metastasis-associated Macrophages 2015
12 MatrixMacrophages Matrix degrading macrophages in cancer growth and invasion 2015
13 BRIDGES Bioinformatic approaches to identify and detect both disease- and drug-related genomic alterations in breast cancer patients 2015
14 S-OS Exosomes as microenvironmental cue for engaging mesenchymal stem cells in osteosarcoma progression 2016
15 CELLETEST Liquid Biopsy blood test in lung cancer diagnosis and monitoring: a next generation noninvasive tumor tracker device 2015
16 MyNano Towards the design of Personalised Polymer-based Combination Nanomedicines for Advanced Stage Breast Cancer Patients 2015
17 ER_disease Defining hormonal cross-talk and the role of mutations in estrogen receptor positive breast cancer 2015
18 ZF-MEL-CHEMBIO Chemical Biology in Zebrafish: Drug-Leads and New Targets in the Melanocyte Lineage and Melanoma 2015
19 PROTEOMICAN Discovery of breast cancer aggressiveness markers using topo-proteomics mapping 2015
20 MetCAF Uncovering the Role of Cancer Associated Fibroblasts in Facilitating Breast Cancer Metastasis 2015
21 ISPIC Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome 2016
22 CholangioConcept Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis. 2015
23 uPET Molecular imaging and targeted therapy of the aggressive phenotype: development of uPAR theranostics for cancer patients 2015
24 AVATAR Integrating Genomics and Avatar Mouse Models to Personalize Pancreatic Cancer Treatment 2015
25 CYTOPRO Profiling of tumour cells in blood for personalized treatment of metastatic cancer 2015
26 RCC-TEST A breakthrough in Renal Cell Carcinoma: Personalized RCC-Test 2016
27 PanCaT Next-generation in vivo models for improved pancreatic cancer therapies 2016
28 HERCULES Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis 2016
29 UM Cure 2020 New therapies for uveal melanoma 2016
30 FORCE Imaging the Force of Cancer 2016
31 Bcl-Inhib Discovery of Bcl-3 inhibitors as Potential Chemopreventive Agent for skin cancer 2015
32 PrECISE PERSONALIZED ENGINE FOR CANCER INTEGRATIVE STUDY AND EVALUATION 2016
33 HOLDING-HANDS Holding hands: cell-cell junctions in breast cancer metastasis and resistance to therapy 2016
34 BARCODE DIAGNOSTICS Next-Generation Personalized Diagnostic Nanotechnologies for Predicting Response to Cancer Medicine 2016
35 PDA_TGFb TGF-beta mediated crosstalk between cancer (stem) cells and tumor microenvironment in pancreatic cancer metastasis 2017
36 RAC Defining the Role of Antioxidants on Cancer progression and metastasis 2016
37 MRCKa in cancer Targeting Cancer Cell Invasion and Metastasis by Inhibition of the Serine Kinase MRCKa 2016
38 DLL4-LVN Targeting the (pre)metastatic lympho-vascular niche: molecular mechanisms and therapeutic implications in melanoma 2017
39 2MoveMate4Melanoma A treatment for BRAF inhibitor resistant melanoma 2016
40 CLONCELLBREAST CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS DYNAMIC EVOLUTION WITH TREATMENT 2017
41 FIBROCAN Defining the immunological interplay between fibroblastic reticular cells and anti-tumour T cells 2016
42 STEM-BCPC Signal Transduction and Epigenetic Mechanisms of Breast Cell Plasticity and Cancer 2016
43 Project ACT Automated autologous cell therapy system 2016
44 NO-META Feasibility study of a NOvel METAbolic liquid biopsy for cancer therapy monitoring 2016
45 tagMDR Identification of Multidrug Resistance for Chemotherapy Guidance in Cancer Using a Lab-on-a-chip Platform 2016
46 MATRICAN Matrix during cancer progression 2016
47 EPIPHARM Development of a ncRNA DNA Methylation Kit for Treatment Guidance in Cancer of Unknown Primary 2017
48 HypoSens Nano-confined photonic system for detection of breast cancer spread to the lymph nodes 2016
49 HYPOXIMMUNO Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia 2016
50 GlycoImaging Imaging and detection of tumor-associated glycan structures on tumor cells 2017
51 IMMUNOSABR Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer 2017
52 SUPRACELL_COMMUN_CCT Supracellular contractility dynamics and cell communication during collective chemotaxis. 2016
53 MetResistance The role of tumour microenvironment in metastatic hormone-refractory prostate cancer 2017
54 SpheroPredict A 3D advanced test for prediction of drug response in secondary liver cancer 2017
55 Monomark A comparative clinical study of a stool-based versus a blood-based screening test for earlydetection of CRC 2017
56 TRIBBLES Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma 2018
57 METMEL Long range-acting drivers of premetastatic niches in melanoma 2017
58 CINK Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers 2018
59 WHOLENICHE Hold it or let it go: a niche decision on cancer growth 2017
60 ONCOSYSTEMS Phenotypic characterization of Liver-derived exosomes populations associated with liver metastasis in pancreatic cancers 2017
61 CTCapture_2.0 Advanced platform for profiling of therapeutic targets and functional analysis of circulating tumour cells in cancer patients 2017
62 META-DORM Mechanobiology of METAstatic and DORMant cancer cells in bone marrow lesions 2018
63 HoldCancerBack What Holds Cancer Cells Back? 2017
64 STOPCa The cryptic path of tumor-microenvironment interactions in prostate cancer 2017
65 COLOSSUS Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions 2018
66 MTrix Mechanical Targeting as an Integrative Approach for Personalized Nanomedicine 2017
67 CombaTCancer Rational combination therapies for metastatic cancer 2018
68 CANCER Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life 2018
69 MATADOR MAmmary chemoresistant Tumor deAth by Directed cell ORientation 2018
70 OMVCRC Engineered bacterial Outer Membrane Vesicles (OMVs) for colorectal cancer immunotherapy 2018
71 MicroCaT Micro-tumor Guided Cancer Therapy Selection MicroCaT 2018
72 MetaRegulation Metabolic regulation of metastatic growth 2018
73 iaFRET An amplified signal imaging software for prognosis of cancer enabling the evaluation of clinicalefficiency of personalised cancer treatments to an unprecedented level. 2018
74 IMMUNOMARK Omics integration for precision cancer immunotherapy 2018
75 PhenoSwitch Phenotype switching: plasticity and/or differentiation of stromal cells and their progenitors within the tumour microenvironment regulate tumour fate. 2018
76 ONCOTHERANOSTICS Advanced Theranostic Nanomedicines for Oncology. Development of new combinatorial therapies for primary and metastatic Breast Cancer. 2019
77 Gal3-BrainMets A novel immunotherapy against brain metastasis: Anti-Galectin-3 2019
78 COLOVOC Reliable and specific urinary biomarkers for colorectal cancer 2019
79 VulneraBAP1 Mechanism and vulnerability of BAP1 loss in tumor metastasis 2018
80 NANOBOTS Tumor-Targeting Nanoengineered Bioorthogonal Technologies to Fight Metastatic Cancers 2018
81 PCaProTreat Multi-omics molecular treatment targets for Prostate Cancer 2018
82 GDCOLCA Understanding gamma delta T cells in colon cancer metastasis 2018
83 QuanTII Quantitative T cell Immunology and Immunotherapy 2018
84 B2B Modeling spontaneous Breast cancer metastasis TO the Bone with a first-of-its-kind 3D device that recapitulates physiological tissue-level complexity. 2018
85 LIPOMET Dietary Influences on Metastasis: How, When, and Why 2018
86 RV001 RV001: An anti-metastatic cancer vaccine 2018
87 SMARTRIOX Disruptive targeted drug delivery system via synergistic combination of intelligent DNA molecular machines and gated mesoporous nanoparticles 2018
88 TETHIS-SBS-CTC TETHIS-SBS-CTC: An innovative diagnostic testing platform to identify and characterize circulating tumour cells (CTCs) in blood samples. 2018
89 UNLEASHAD Unleashing the curative potential of cancer immunotherapy 2018
90 CytoPro A breakthrough cancer diagnostic instrument to save 3000 years of human lives annually and up 2018
91 ImmunoCode Digital Single Cell Immunology: Decoding Cellular Interactions for Improved Immunotherapy 2018
92 FURTHER Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients with Bone Metastasis 2019
93 POLYMMUNE Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment 2019
94 METANICHE Regulation of bone metastases by age-associated angiocrine signals 2019
95 CANCEREVO Deciphering and predicting the evolution of cancer cell populations 2019
96 FanCY Flow and Deformation of Cancer tumours near Yielding 2019
97 PACA-MET Genome-wide surveys and functional analysis of pancreatic cancer metastasis drivers 2019
98 PREFERABLE Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life 2019
99 AURORAX Advancing cancer detection through metabolism-based diagnostics 2019
100 POCON Proof-of-Concept of a nanobody targeting Osteopontin to inhibit colorectal cancer development 2019
101 Cluster-Buster Development of small molecule inhibitors of circulating tumor cell clusters 2019
102 CRC-MTOs Colorectal Cancer Mouse Tumor Organoids as Pre-clinical Models for Therapeutical Testing 2018
103 Biosensor Design Engineering Chemotactic Biosensors for a Diverse Spectrum of Metastatic Markers 2020
104 INHuMAN Intra-tumoral heterogeneity in NRAS-driven metastatic melanoma 2019
105 EVOMET The rise and fall of metastatic clones under immune attack 2019
106 ImmunoMECH High-performance biomechanical model of combined immunotherapy and anti-angiogenic cancer treatment 2019
107 EndoPos Endosome positioning in tumour-stroma interactions 2019
108 AR-DDR Co-targeting androgen receptor signalling and DNA damage repair for precision therapy in advanced prostate cancer 2019
109 PB_dormancy Insertional mutagenesis to identify molecular mechanisms of breast cancer dormancy and metastasis 2020
110 MetaTarGet Targeting metabolic regulation in metastasis formation 2019
111 IEOCCD THE IMPACT OF THE ENVIRONMENT AND ONCOGENESIS ON CANCER CELL DIVISIONS 2019
112 MechTransition Regulatory mechanisms controlling a new mechanical Epithelial to Mesenchymal Transition in zebrafish 2020
113 PDX-PC Elucidation of tumour cell plasticity mechanisms associated to treatment in metastatic prostate cancer 2019
114 INFORM Innovative Electrochemical Multiplex Biosensor for Detection and Quantification of Clinically Relevant Circulating miRNAs 2020
115 ICE-METs Interstitium-on-a-chip to explore its role in cancer metastasis 2019
116 METASPINE Comprehensive experimental and computational mechanical characterisation of metastatic vertebrae 2019
117 NanoProt-ID Proteome profiling using plasmonic nanopore sensors 2019
118 PROTEUS Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection 2019
119 CHyMERA Monitoring cancer heterogeneity based on the dynamic assessment of the Warburg effect under metabolic perturbation 2019
120 3DBrainStrom Brain metastases: Deciphering tumor-stroma interactions in three dimensions for the rational design of nanomedicines 2019
121 MS Unravelling the molecular and cellular mechanism of metastasis 2020
122 NEXIM A Next-generation targeted immuno-oncology therapy 2019
123 TK-NEO Personalized Cancer Immunotherapy through DNA-EP vaccines 2019
124 THERADNET International NETwork for training and innovations in THErapeutic RADiation 2019
125 PAVE A nanovaccine Approach for the treatment of Pancreatic Cancer 2019
126 RV001 RV001: An anti-metastatic cancer vaccine 2019
127 PROT-RESIST Toward the Commercialization of a Proteolytically Resistant APPI Variant for Inhibiting Metastasis in Prostate and Pancreatic Cancer 2019
128 ImOPac GemciTest: An innovative In Vitro Diagnostic for the decision-making process of pancreatic cancer treatment 2019
129 STI-001 Turn Cancer Immunotherapy Effective in Most Patients 2019
130 Meta-Targeting Macro-Nanomedicine to Treat Metastatic Cancer 2020
131 ALTER-brain Metastasis-associated altered molecular patterns in the brain 2020
132 BRCAstem Monitoring cancer stem cell dynamics and therapeutic response in BRCA2-deficient breast tumour cells 2020
133 METABONE A new approach of metastatic bone fracture prediction using a patient-specific model including metastatic tissue, daily-life activities and local failure criteria 2020
134 NetriCan Characterization of the role of netrin-1 in the regulation of the Epithelial-to-Mesenchymal Transition during tumor progression. 2020
135 NANOCRISPR NANODELIVERY OF SPECIFIC GENOME ENGINEERING TOOLS AS A NOVEL THERAPEUTIC APPROACH FOR AGGRESSIVE PROSTATE CANCERS 2021
136 RabTarget4Metastasis Targeting Rab27A with covalent inhibitors for the treatment of metastatic breast cancer 2020
137 ONCO-VAX A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine 2020
138 RCC_Evo Modelling the Predictability and Repeatability of Tumour Evolution in Clear Cell Renal Cell Cancer 2020